What is the definition of Drug Induced Dyskinesia?

Drug induced dyskinesia is an involuntary movement disorder. Signs and symptoms include repetitive and irregular motions of the mouth, face, limbs and/or trunk. Treatment with antipsychotic drugs and levodopa (commonly used to treat Parkinson disease) are well recognized causes of drug-induced dyskinesia. Dyskinesia develops in around 40% of people with Parkinson's disease who have been on levodopa treatment for four to six years. Tardive dyskinesia is a severe form of drug-induced dyskinesia due to antipsychotic treatments. Tardive dyskinesia develops in 5% of people per year of treatment.

What are the alternative names for Drug Induced Dyskinesia?

  • Dyskinesia, drug induced

What are the causes for Drug Induced Dyskinesia?

The following medications have caused drug-induced dyskinesia in some individuals:
  • Levodopa
  • Chlorpromazine
  • Fluphenazine
  • Haloperidol
  • Trifluoperazine
  • Flunarizine (Sibelium)
  • Metoclopramide
  • Prochlorperazine
  • Condition: Tourette Syndrome
  • Journal: JAMA network open
  • Treatment Used: Flexible-Dose Deutetrabenazine
  • Number of Patients: 119
  • Published —
The objective of this study was to examine whether deutetrabenazine is effective and safe for the treatment of Tourette syndrome in children and adolescents.
  • Condition: Constrictive Pericarditis with Multiple Organ Failure after Coronary Artery Bypass Grafting (CABG)
  • Journal: Kyobu geka. The Japanese journal of thoracic surgery
  • Treatment Used: Surgery and Negative Pressure Wound Therapy
  • Number of Patients: 1
  • Published —
This case report describes a 67-year-old male patient diagnosed with constrictive pericarditis with multiple organ failure after coronary artery bypass grafting (CABG) treated with surgery and negative pressure wound therapy.
Clinical Trial
  • Status: Active, not recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 10
  • Start Date: November 2016
Osteopathic Manual Treatment of Postural Abnormality, Pain, and Autonomic Control of Cardiac Function in People With Parkinson's Disease and Truncal Dystonia
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 40
  • Start Date: March 15, 2021
Addressing Mental Health Disparities in Spanish Speaking Latina Breast Cancer Patients